1,365
Views
7
CrossRef citations to date
0
Altmetric
Research Paper

Immunogenicity and safety of 23-valent pneumococcal polysaccharide vaccine as a booster dose in 12- to 18-month-old children primed with 3 doses of 7-valent pneumococcal conjugate vaccine

, , , , &
Pages 1859-1865 | Received 14 Nov 2013, Accepted 25 Mar 2014, Published online: 23 Apr 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Pablo Obando-Pacheco, Irene Rivero-Calle, Peter Francis Raguindin & Federico Martinón-Torres. (2019) DTaP5-HBV-IPV-Hib pediatric hexavalent combination vaccine for use in children from 6 weeks through to 4 years of age. Expert Review of Vaccines 18:11, pages 1115-1126.
Read now
Pope Kosalaraksa, Kulkanya Chokephaibulkit, Suwat Benjaponpitak, Chitsanu Pancharoen, Sunate Chuenkitmongkol, Siham B'Chir, Xavier Da Costa & Emmanuel Vidor. (2018) Persistence of hepatitis B immune memory until 9–10 years of age following hepatitis B vaccination at birth and DTaP-IPV-HB-PRP∼T vaccination at 2, 4 and 6 months. Human Vaccines & Immunotherapeutics 14:5, pages 1257-1265.
Read now
Yang Wang, Jingxin Li, Yuxiao Wang, Wei Gu & Fengcai Zhu. (2018) Effectiveness and practical uses of 23-valent pneumococcal polysaccharide vaccine in healthy and special populations. Human Vaccines & Immunotherapeutics 14:4, pages 1003-1012.
Read now

Articles from other publishers (4)

Shuo Feng, Julie McLellan, Nicola Pidduck, Nia Roberts, Julian P.T. Higgins, Yoon Choi, Alane Izu, Mark Jit, Shabir A. Madhi, Kim Mulholland, Andrew J. Pollard, Beth Temple & Merryn Voysey. (2023) Immunogenicity and seroefficacy of 10-valent and 13-valent pneumococcal conjugate vaccines: a systematic review and network meta-analysis of individual participant data. eClinicalMedicine 61, pages 102073.
Crossref
Anita van den Biggelaar, William Pomat, Geraldine Masiria, Sandra Wana, Birunu Nivio, Jacinta Francis, Rebecca Ford, Megan Passey, Lea-Ann Kirkham, Peter Jacoby, Deborah Lehmann & Peter Richmond. (2019) Immunogenicity and Immune Memory after a Pneumococcal Polysaccharide Vaccine Booster in a High-Risk Population Primed with 10-Valent or 13-Valent Pneumococcal Conjugate Vaccine: A Randomized Controlled Trial in Papua New Guinean Children. Vaccines 7:1, pages 17.
Crossref
C Evans, E Bateman, R Steven, M Ponsford, A Cullinane, C Shenton, G Duthie, C Conlon, S Jolles, A P Huissoon, H J Longhurst, T Rahman, C Scott, G Wallis, S Harding, A R Parker & B L Ferry. (2018) Measurement of Typhi Vi antibodies can be used to assess adaptive immunity in patients with immunodeficiency. Clinical and Experimental Immunology 192:3, pages 292-301.
Crossref
Sanjay Jayasinghe, Clayton Chiu, Rob Menzies, Deborah Lehmann, Heather Cook, Carolien Giele, Vicki Krause & Peter McIntyre. (2015) Evaluation of impact of 23 valent pneumococcal polysaccharide vaccine following 7 valent pneumococcal conjugate vaccine in Australian Indigenous children. Vaccine 33:48, pages 6666-6674.
Crossref